Sector: Health Care
Director information for NOVOCURE LTD (data for year 2026)
| Name | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| Allyson Ocean | Professor of Clinical Medicine at the Weill Medical College of Cornell University; Medical oncologist and attending physician in gastrointestinal oncology at NewYork-Presbyterian Hospital/Weill Cornell Medical Center; Medical oncologist at The Jay Monahan Center for Gastrointestinal Health | 54 | [] | ["Nominating and Corporate Governance"] | 2026 |
| Asaf Danziger | Senior Advisor to Chief Executive Officer, Novocure | 59 | [] | [] | 2026 |
| Ashley Cordova | Chief Executive Officer and director | [] | [] | 2026 | |
| David Hung | Founder, President and Chief Executive Officer, Nuvation Bio Inc. | 68 | [] | ["Nominating and Corporate Governance"] | 2026 |
| Frank Leonard | Chief Executive Officer, NovoCure Limited | 46 | [] | [] | 2026 |
| Jeryl Hilleman | Former Chief Financial Officer of Intersect ENT, Inc. | 68 | [] | ["Audit"] | 2026 |
| Kinyip Gabriel Leung | Former Vice Chairman, Novocure Board | 64 | [] | ["Nominating and Corporate Governance"] | 2026 |
| Kristin Stafford | Chief Financial Officer, Zymeworks Inc. | 44 | [] | ["Compensation"] | 2026 |
| Martin Madden | Former Vice President Research and Development of DePuy-Synthes of Johnson & Johnson | 65 | [] | ["Audit","Compensation"] | 2026 |
| Nicolas Leupin | Chief Medical Officer | [] | [] | 2026 | |
| Timothy Scannell | Former President and Chief Operating Officer, Stryker Corporation | 61 | [] | ["Audit"] | 2026 |
| Uri Weinberg | Chief Medical and Innovation Officer | [] | [] | 2026 | |
| William Doyle | Executive Chairman, Novocure | 63 | [] | [] | 2026 |
| William Vernon | Former Chief Executive Officer of Kraft Foods Group, Inc. | 70 | [] | ["Compensation"] | 2026 |
